The effect of polypropylene vials on lithotripter shock waves.

Ultrasound Med Biol

Applied Physics Laboratory, University of Washington, Seattle 98105, USA.

Published: October 1997

In studies to understand the mechanisms responsible for shock wave lithotripsy (SWL) cell injury, we observed that shock waves (SWs) are influenced by the shape of the specimen vial. Lytic injury to kidney cells treated in a Dornier HM3 lithotripter was higher (p < 0.0001) when SWs entered the vial through the flat end (cap end) compared to the round end. Measurements of the acoustic field within polypropylene vials were carried out using both lithotripter SWs and pulsed ultrasound (US) in the megahertz frequency range. We compared pressure amplitudes inside the round and flat vials and found significant differences. When SWs entered through the round end, the average peak positive pressure was 40% of free-field pressure, due mostly to a dramatic reduction in pressure off axis. The average peak pressure inside the flat vial was twice that of the round vial. Experiments with US demonstrated that sound field focusing was induced by the curved interface of the round vial. Ray analysis for the round vial indicates the presence of "hot spots" on axis and "cold spots" off axis, in qualitative agreement with pressure profiles. We conclude that the shape of the specimen vial is an important factor that should be considered in model systems of SWL cell injury.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0301-5629(97)00026-4DOI Listing

Publication Analysis

Top Keywords

round vial
12
polypropylene vials
8
shock waves
8
swl cell
8
cell injury
8
shape specimen
8
specimen vial
8
sws entered
8
average peak
8
spots" axis
8

Similar Publications

Background: Over the past 4 decades, obesity has escalated into a global epidemic, with its worldwide prevalence nearly tripling. Pharmacological treatments have evolved with the recent development of glucagon-like peptide 1 agonists, such as semaglutide. However, off-label use of drugs such as Ozempic for cosmetic weight loss has surged in popularity, raising concerns about potential misuse and the emergence of substandard and falsified products in the unregulated supply chain.

View Article and Find Full Text PDF

Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer.

Bladder Cancer

October 2024

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Background: Trimodality therapy (TMT) is a viable option for muscle-invasive localized bladder cancer, providing an alternative to radical cystectomy in properly selected patients. The approval of novel therapeutics in different stages of bladder cancer treatment has sparked interest in exploring concurrent systemic therapies with radiation in clinical trials to enhance long-term outcomes. Achieving uniformity in trial eligibility criteria and endpoint definitions is imperative in describing clinical significance, comparing trials, and changing standard of care guidelines.

View Article and Find Full Text PDF
Article Synopsis
  • The study systematically reviews evidence on cancer drug wastage and the effectiveness of various mitigation methods, assessing articles from databases like Scopus, PubMed, and EMBASE.
  • Out of 6298 articles, 94 were included, with most focusing on high-income countries and recent publications, revealing that a significant number report on mitigation methods like vial sharing and dose rounding.
  • Findings show that cancer drug wastage costs are notably higher in the US compared to other countries, emphasizing the need for better reporting standards for drug wastage in future research to improve healthcare expenditure efficiency.
View Article and Find Full Text PDF

Purpose: Globally, cancer drug expenditure exceeds $185 in US dollars (USD) billion, with the United States contributing $75 (USD) billion. Many cancer drug doses are calculated on the basis of body weight or body surface area, which often results in leftover drug in partially used single-dose vials (SDVs). The cost of wasted drug is a huge financial burden on the US health care system.

View Article and Find Full Text PDF

New Therapeutic Horizons for Advanced or Metastatic Penile Cancer.

Urol Clin North Am

August 2024

Department of Oncology, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10 - Magnuson Clinical Center, Room 13N240, Bethesda, MD 20892, USA. Electronic address:

Penile cancer is a rare malignancy with a poor prognosis. Studies with single-agent immune checkpoint inhibitors (ICIs) have demonstrated efficacy, but response rates are low. Studies combining ICIs with both chemotherapy and targeted therapy are ongoing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!